Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

CD24 and BAG-1 suggested as prognostic markers for aggressive breast cancer

Feb. 12, 2007

CHK1 drug discovery program advances

Feb. 12, 2007

Enrollment completed in safety study of EOquin in noninvasive bladder cancer

Feb. 12, 2007

Sutent approved with new data for advanced renal cell carcinoma

Feb. 9, 2007

Japanese study supports further evaluation of hypertension chemotherapy

Feb. 9, 2007

Kallikrein 6 studied as a prognostic marker and a therapeutic target in ovarian cancer

Feb. 9, 2007

Seliciclib to be investigated for nasopharyngeal cancer

Feb. 9, 2007

UCB and ImClone terminate CDP-791 agreement

Feb. 9, 2007

Pro-Pharmaceuticals commences NDA filing for Davanat

Feb. 8, 2007

European label extension sought for Evoltra for elderly patients with AML

Feb. 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...